MTX-463

· Mediar Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MTX-463, covering 2025-01-17 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males [Phase 1]